Abstract:Novel hydrogels (termed HCD hydrogels) were synthesized based on human-like collagen (HLC) and chitosan (CS) cross-linked with dialdehyde starch (DAS). The biological stability and biocompatibility of HCD hydrogels were determined through in vitro and in vivo tests. The mechanism of hydrogel formation was studied using Fourier transform infrared spectroscopy (FTIR), which showed that covalent bonds formed via acetalization and Schiff base reactions. Biological stability was evaluated in vitro by degrading HCD hydrogels with class I collagenase, class II collagenase, and both class I and class II collagenases and in vivo after subcutaneously injecting HCD into an animal model. The biological characteristics of HCD hydrogels was studied by two methods: (i) MTT and cytomorphology cytotoxicity and cytocompatibility and (ii) in vivo, whereby histomorphometry, transmission electron microscopy (TEM), and immunohistochemistry were used to compare different types of surgically introduced hydrogels, our HCD hydrogels, SunMax Collagen Implant hydrogels (SUM hydrogels), and OUTLINE&EVOLUTION Injectable Synthetic Gel hydrogels (EVL hydrogels). The in vivo analyses were performed at 1, 9, 12, and 28 weeks after surgery. The hydrogel biodegradation results showed that the normalized residual weight (W-R) of HCD hydrogels varied with DAS content. In vitro, we found that the minimum WR of HCD hydrogels was 42.19% after 28 weeks when degraded by both types of class I and class II collagenase. The MTT assay indicated that the minimum relative growth rate (RGR) of cells was 93% after they were incubated with HCD hydrogels for 7 days, suggesting good cytocompatibility. In vivo histomorphometry results indicated that HCD hydrogels effectively filled tissue voids and did not cause redness, edema, festering, or color changes. In addition, a few vessels grew into the hydrogel and a thin fibrous capsule was eventually produced. TEM and immunohistochemistry studies suggested that HCD hydrogels produced less intense inflammatory responses than those produced by SUM hydrogels and EVL hydrogels. Overall, HCD hydrogels afford both enhanced biological stability and excellent biocompatibility, making them potentially promising for skin patch scaffolds, wrinkle treatments, and tissue cavity fillers.

Biocompatibility and in vivo degradation of chitosan based hydrogels as potential drug carrier.

In Vitro and in Vivo Evaluation of 3D Biodegradable Thermo/ph Sensitive Sol-Gel Reversible Hydroxybutyl Chitosan Hydrogel.

A Novel Chitosan-Collagen-Based Hydrogel For Use As A Dermal Filler: Initial In Vitro And In Vivo Investigations

Biocompatibility Evaluation of N,O-hexanoyl Chitosan As a Biodegradable Hydrophobic Polycation for Controlled Drug Release.

Study the Biodegradation of a Injection Human-Like Collagen Hydrogel

Novel Bioresorbable Hydrogels Prepared From Chitosan-Graft-Polylactide Copolymers

in vitro and in vivo Morphology and Degradation of Chitosan Based Thermosensitive Hydrogel as Drug Release Matrix

Preparation, Cytotoxicity and Degradability of Chitosan-Based Thermosensitive Hydrogels As Drug Delivery System

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity, in vivo degradation and drug release.

Covalent and Injectable Chitosan-Chondroitin Sulfate Hydrogels Embedded with Chitosan Microspheres for Drug Delivery and Tissue Engineering.

Ph-Sensitive Carboxymethyl Chitosan Hydrogels Via Acid-Labile Ortho Ester Linkage for Potential Biomedical Applications.

PEG-g-chitosan thermosensitive hydrogel for implant drug delivery: cytotoxicity,<i>in vivo</i>degradation and drug release

Biocompatibility and Characteristics of Chitosan/cellulose Acetate Microspheres for Drug Delivery

Biocompatibility and Characteristics of Injectable Chitosan-Based Thermosensitive Hydrogel for Drug Delivery

Covalently crosslinked chitosan hydrogel: properties of in vitro degradation and chondrocyte encapsulation.

Injectable Hydroxypropyl Chitin Hydrogels Embedded with Carboxymethyl Chitin Microspheres Prepared Via a Solvent-Free Process for Drug Delivery.

Disulfide-crosslinked chitosan hydrogel for cell viability and controlled protein release

Pharmacokinetics and Biodegradation Performance of a Hydroxypropyl Chitosan Derivative

Pharmacokinetics and Biodegradation Mechanisms of a Versatile Carboxymethyl Derivative of Chitosan in Rats: in Vivo and in Vitro Evaluation.

Hemostatic Performance of Chitosan-Based Hydrogel and Its Study on Biodistribution and Biodegradability in Rats.

Preparation Of Photo-Crosslinking Carboxymethyl Chitosan Hydrogel For Sustained Drug Release